Annual Retained Earnings
-$174.85 M
-$16.70 M-10.56%
December 1, 2023
Summary
- As of March 3, 2025, NBY annual retained earnings is -$174.85 million, with the most recent change of -$16.70 million (-10.56%) on December 1, 2023.
- During the last 3 years, NBY annual retained earnings has fallen by -$38.79 million (-28.51%).
- NBY annual retained earnings is now -2145.11% below its all-time high of -$7.79 million, reached on December 31, 2005.
Performance
NBY Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$182.25 M
-$2.22 M-1.23%
September 1, 2024
Summary
- As of March 3, 2025, NBY quarterly retained earnings is -$182.25 million, with the most recent change of -$2.22 million (-1.23%) on September 1, 2024.
- Over the past year, NBY quarterly retained earnings has dropped by -$16.57 million (-10.00%).
- NBY quarterly retained earnings is now -2240.07% below its all-time high of -$7.79 million, reached on December 31, 2005.
Performance
NBY Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
NBY Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -10.6% | -10.0% |
| 3 y3 years | -28.5% | -11.2% |
| 5 y5 years | -52.1% | -11.2% |
NBY Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -23.2% | at low | -28.4% | at low |
| 5 y | 5-year | -39.9% | at low | -45.8% | at low |
| alltime | all time | -2145.1% | at low | -2240.1% | at low |
NovaBay Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$182.25 M(+1.2%) |
| Jun 2024 | - | -$180.03 M(+0.9%) |
| Mar 2024 | - | -$178.44 M(+2.1%) |
| Dec 2023 | -$174.85 M(+10.6%) | -$174.85 M(+5.5%) |
| Sep 2023 | - | -$165.68 M(+1.1%) |
| Jun 2023 | - | -$163.92 M(+2.5%) |
| Mar 2023 | - | -$159.89 M(+1.1%) |
| Dec 2022 | -$158.15 M(+11.5%) | -$158.15 M(+5.5%) |
| Sep 2022 | - | -$149.95 M(+4.0%) |
| Jun 2022 | - | -$144.15 M(+1.5%) |
| Mar 2022 | - | -$142.00 M(+0.1%) |
| Dec 2021 | -$141.89 M(+4.3%) | -$141.89 M(+0.1%) |
| Sep 2021 | - | -$141.73 M(+1.6%) |
| Jun 2021 | - | -$139.44 M(+1.4%) |
| Mar 2021 | - | -$137.58 M(+1.1%) |
| Dec 2020 | -$136.06 M(+8.8%) | -$136.06 M(+1.3%) |
| Sep 2020 | - | -$134.31 M(+2.5%) |
| Jun 2020 | - | -$131.09 M(+3.5%) |
| Mar 2020 | - | -$126.61 M(+1.3%) |
| Dec 2019 | -$125.02 M(+8.7%) | -$125.02 M(+2.2%) |
| Sep 2019 | - | -$122.34 M(+0.2%) |
| Jun 2019 | - | -$122.06 M(+2.1%) |
| Mar 2019 | - | -$119.53 M(+4.0%) |
| Dec 2018 | -$114.98 M(+3.5%) | -$114.98 M(+1.1%) |
| Sep 2018 | - | -$113.71 M(+1.4%) |
| Jun 2018 | - | -$112.17 M(+1.4%) |
| Mar 2018 | - | -$110.58 M(-0.4%) |
| Dec 2017 | -$111.07 M(+7.1%) | -$111.07 M(-0.7%) |
| Sep 2017 | - | -$111.87 M(+2.2%) |
| Jun 2017 | - | -$109.42 M(+1.6%) |
| Mar 2017 | - | -$107.68 M(+3.9%) |
| Dec 2016 | -$103.67 M(+14.5%) | -$103.67 M(+1.6%) |
| Sep 2016 | - | -$102.02 M(+3.8%) |
| Jun 2016 | - | -$98.29 M(+2.8%) |
| Mar 2016 | - | -$95.60 M(+5.6%) |
| Dec 2015 | -$90.52 M | -$90.52 M(+4.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2015 | - | -$86.32 M(+6.5%) |
| Jun 2015 | - | -$81.07 M(+6.4%) |
| Mar 2015 | - | -$76.19 M(+6.5%) |
| Dec 2014 | -$71.55 M(+27.0%) | -$71.55 M(+6.7%) |
| Sep 2014 | - | -$67.08 M(+6.7%) |
| Jun 2014 | - | -$62.86 M(+4.9%) |
| Mar 2014 | - | -$59.92 M(+6.3%) |
| Dec 2013 | -$56.35 M(+39.8%) | -$56.35 M(+7.9%) |
| Sep 2013 | - | -$52.22 M(+8.0%) |
| Jun 2013 | - | -$48.37 M(+9.1%) |
| Mar 2013 | - | -$44.32 M(+9.9%) |
| Dec 2012 | -$40.31 M(+21.1%) | -$40.31 M(+6.2%) |
| Sep 2012 | - | -$37.96 M(-0.2%) |
| Jun 2012 | - | -$38.04 M(+6.2%) |
| Mar 2012 | - | -$35.81 M(+7.6%) |
| Dec 2011 | -$33.28 M(+18.0%) | -$33.28 M(+12.2%) |
| Sep 2011 | - | -$29.66 M(-0.4%) |
| Jun 2011 | - | -$29.76 M(-1.4%) |
| Mar 2011 | - | -$30.19 M(+7.0%) |
| Dec 2010 | -$28.20 M(+18.0%) | -$28.20 M(-0.6%) |
| Sep 2010 | - | -$28.36 M(+6.1%) |
| Jun 2010 | - | -$26.72 M(+4.7%) |
| Mar 2010 | - | -$25.52 M(+6.8%) |
| Dec 2009 | -$23.89 M(-10.1%) | -$23.89 M(-12.5%) |
| Sep 2009 | - | -$27.31 M(+0.4%) |
| Jun 2009 | - | -$27.20 M(+1.1%) |
| Mar 2009 | - | -$26.91 M(+1.2%) |
| Dec 2008 | -$26.59 M(+43.9%) | -$26.59 M(+6.1%) |
| Sep 2008 | - | -$25.05 M(+6.3%) |
| Jun 2008 | - | -$23.56 M(+11.4%) |
| Mar 2008 | - | -$21.15 M(+14.5%) |
| Dec 2007 | -$18.47 M(+41.3%) | -$18.47 M(+8.2%) |
| Sep 2007 | - | -$17.08 M(+10.0%) |
| Jun 2007 | - | -$15.52 M(+11.1%) |
| Mar 2007 | - | -$13.97 M(+6.8%) |
| Dec 2006 | -$13.07 M(+67.9%) | -$13.07 M(+67.9%) |
| Dec 2005 | -$7.79 M | -$7.79 M |
FAQ
- What is NovaBay Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for NovaBay Pharmaceuticals?
- What is NovaBay Pharmaceuticals annual retained earnings year-on-year change?
- What is NovaBay Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for NovaBay Pharmaceuticals?
- What is NovaBay Pharmaceuticals quarterly retained earnings year-on-year change?
What is NovaBay Pharmaceuticals annual retained earnings?
The current annual retained earnings of NBY is -$174.85 M
What is the all time high annual retained earnings for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high annual retained earnings is -$7.79 M
What is NovaBay Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, NBY annual retained earnings has changed by -$16.70 M (-10.56%)
What is NovaBay Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of NBY is -$182.25 M
What is the all time high quarterly retained earnings for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high quarterly retained earnings is -$7.79 M
What is NovaBay Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, NBY quarterly retained earnings has changed by -$16.57 M (-10.00%)